What are the treatment options for eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Eczema

A stepwise approach beginning with topical therapies is the recommended first-line treatment for most patients with eczema, with phototherapy and systemic therapies reserved for more severe or refractory cases. 1

First-Line Treatments: Topical Therapies

Topical Corticosteroids

  • Potent and moderate topical corticosteroids are more effective than mild corticosteroids for treating eczema, particularly for moderate to severe cases 2, 3
  • Apply twice daily for up to 4 weeks initially for flares 1
  • Once-daily application of potent topical corticosteroids is as effective as twice-daily application 2, 4
  • Potency selection guidelines:
    • Mild (Class 5-7): Face, genitals, skin folds, infants
    • Moderate (Class 3-4): Trunk, extremities, children
    • Potent/Very potent (Class 1-2): Reserved for thick, lichenified, or treatment-resistant lesions 1
  • Weekend therapy (proactive approach) applying topical corticosteroids twice weekly can prevent flares after improvement 1, 2
  • Monitor for adverse effects including skin atrophy, striae, telangiectasia, and purpura 1

Topical Calcineurin Inhibitors

  • Strongly recommended for mild to moderate eczema, particularly for sensitive areas 1
  • No risk of skin atrophy, making them suitable for long-term use 1
  • Examples include:
    • Tacrolimus 0.1% - ranked among the most effective topical treatments 3
    • Pimecrolimus (Elidel) - less effective than moderate/potent corticosteroids and 0.1% tacrolimus 5
  • Pimecrolimus should not be used:
    • Continuously for long periods
    • In children under 2 years old
    • In patients with weakened immune systems 6
  • Most common side effects include burning or warmth sensation at application site 6, 5

Topical PDE-4 Inhibitors

  • Crisaborole 2% is strongly recommended for mild to moderate eczema 1
  • May cause application site reactions more commonly than topical steroids 3

Topical JAK Inhibitors

  • Strongly recommended for mild to moderate eczema 1
  • Ruxolitinib 1.5%, delgocitinib 0.5% or 0.25% ranked among most effective topical treatments 3

Second-Line Treatment: Phototherapy

  • Conditionally recommended for moderate to severe eczema when topical therapies are insufficient 1
  • Narrowband UVB is generally preferred for adolescents, under specialist supervision 1
  • Safe and effective for moderate to severe atopic dermatitis when first-line treatments are inadequate 7

Third-Line Treatments: Systemic Therapies

Biologics

  • Strongly recommended for severe, widespread, or refractory eczema 1
  • Examples include dupilumab and tralokinumab 1, 7

Oral JAK Inhibitors

  • Strongly recommended for severe, widespread, or refractory eczema 1
  • Examples include abrocitinib, baricitinib, and upadacitinib 1

Immunomodulators

  • Conditionally recommended for severe, widespread, or refractory eczema 1
  • Examples include cyclosporine, methotrexate, azathioprine, and mycophenolate 1

Systemic Corticosteroids

  • Conditionally recommended against due to rebound flares upon discontinuation and adverse effects with long-term use 1
  • May be considered as short-term intervention (<7 days) for severe acute exacerbations when other options have failed 1

Skin Care and Prevention

  • Apply fragrance-free emollients 3-8 times daily, even when skin appears normal 1
  • Preferably apply emollients immediately after bathing to lock in moisture 1
  • Use gentle, pH-neutral synthetic detergents instead of soap 1
  • Avoid irritants such as perfumes, deodorants, and alcohol-based lotions 1
  • Identify and eliminate triggering substances 1
  • Consider air purifiers to reduce PM 2.5 exposure, especially during dry moderate weather conditions 1

Infection Prevention and Treatment

  • Treat clinically evident infections with appropriate antibiotics 1
  • Consider antiseptic washes with aqueous chlorhexidine 0.05% for erosive lesions 1
  • Bleach baths with 0.005% sodium hypochlorite twice weekly can help prevent infections 1
  • Evidence does not support routine use of oral or topical antistaphylococcal treatments for infected eczema 4

Important Considerations and Pitfalls

  1. Avoid under-treatment: More aggressive use of topical therapies using the "get control then keep control" regimen is recommended 4

  2. Avoid unnecessary treatments:

    • Oral antihistamines are not recommended as they do not reduce pruritus 4, 7
    • Silk clothing, ion-exchange water softeners, and emollient bath additives have not shown benefit 4
    • Probiotics have not been shown effective for treating eczema 4
  3. Safety monitoring:

    • Risk of skin thinning is low with short-term use of topical steroids (1% across studies) 2
    • Skin thinning risk increases with higher potency steroids 2
    • Long-term use (6-60 months) of topical steroids showed skin thinning in only 0.3% of participants 3
  4. When to refer to specialists:

    • Diagnostic doubt
    • Failure to respond to maintenance treatment with appropriate topical steroids
    • When second-line treatment is required 1

References

Guideline

Atopic Dermatitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Research

Topical Anti-Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta-Analysis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2024

Research

Topical pimecrolimus for eczema.

The Cochrane database of systematic reviews, 2007

Research

Atopic Dermatitis: Diagnosis and Treatment.

American family physician, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.